Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 136117 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 138076 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 165187 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 174127 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 207617 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 265028 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 277720 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 285067 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 326297 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 343318 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 350427 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 355524 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 358653 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 360911 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 368442 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 372122 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 380442 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 382019 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 393712 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 397317 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 437030 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 441079 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 450619 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 456236 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 457233 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 464676 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 502820 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 516023 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 529530 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 534083 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 552083 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 552921 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 557971 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 606586 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 607547 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 612395 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 619156 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 620209 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 632344 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 633425 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 641368 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 645469 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 646395 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 662924 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 665156 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 669913 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 679946 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 685136 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 691743 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 694010 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 694089 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 694976 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 717156 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 720693 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 736850 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 737905 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 744240 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 747311 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 749911 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 759234 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 770234 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 773066 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 776796 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 785005 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 786556 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 790294 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 803280 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 809520 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 809809 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 834551 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 862343 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 862593 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 881978 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 898948 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 904202 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 921151 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 926839 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 938949 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 945045 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 967673 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 981039 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 996741 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1012406 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1022219 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1070131 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1070366 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1125325 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1216820 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1226469 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1276902 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1300038 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1301475 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1304133 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1329923 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1362408 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1384507 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1411511 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1417184 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1486405 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | PALMITOLEIC ACID (CAS# 373-49-9); (M-H)- | 1556479 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |